Embecta Corp. Common Stock
EMBCEmbecta Corp. (EMBC) is a global diabetes care company focused on providing innovative medical products and solutions. Originally part of Becton, Dickinson and Company (BD), Embecta became an independent entity specializing in diabetes management, including insulin delivery devices and related products. The company aims to improve the quality of life for individuals with diabetes through its portfolio of trusted, high-quality healthcare solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 15, 2025 | $0.15 | 2025-08-29 | 2025-08-29 |
| June 13, 2025 | $0.15 | 2025-05-28 | 2025-05-28 |
| March 14, 2025 | $0.15 | 2025-02-28 | 2025-02-28 |
| December 18, 2024 | $0.15 | 2024-12-06 | 2024-12-06 |
| September 13, 2024 | $0.15 | 2024-08-27 | 2024-08-27 |
Dividends Summary
- Embecta Corp. Common Stock has issued 13 dividend payments over the past 3 years
- The most recent dividend was paid 70 days ago, on September 15, 2025
- The highest dividend payed out to investors during this period was $0.15 per share
- The average dividend paid during this period was $0.15 per share.
Company News
Embecta Corp. announced two board member departures: David J. Albritton resigning immediately and LTG David F. Melcher retiring at the 2026 annual stockholder meeting. The company plans to appoint Dev Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director.
Becton Dickinson reported strong Q1 2025 results, with revenue and EPS beating estimates. However, the company lowered its fiscal year 2025 outlook and announced plans to separate its Biosciences and Diagnostic Solutions business by fiscal 2026.
CIXXF, JXN and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 15, 2024.
